CTIBiotech
CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come from all over the world, with particular emphasis for Europe and Asia. Innovative solutions for human benefit in the fields of cancer, dermatology and regenerative medecine.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
CTIPharma
95% of new drug candidates fail cancer clinical trials, costing billions to the pharmaceutical industry and delaying new treatments for patients.
Robust predictive human cell bioassays support faster development of preclinical trials thereby saving time and money.
We offer: R&D, drug testing, medical device co-development and testing, bioassay co-conception and open lab. We provide fully functioning 3D tissue models and specific cell models from patients which improves efficacy given their proximity to human physiology.
For: Pharmaceutical industry (cancer research, regenerative medicine, medical devices), public and private research institutions, contract research organisations.
Key product innovations:
- World’s first mini liver as part of a NASA research programme
- World’s first nervous tissue model
- Stem cell applications
- 3D microtumours
CTISkin
Efficient cosmetics and skin care products require innovation and claim substantiation.
Human skin models provide the means to test new product ideas with scientific credibility.
We offer: In house tests, off the shelf models, co-development/innovation. Open lab using complex skin models from any age range and typology. Skin biopsies and in-house research.
For: Cosmetic and dermatology industries
Key product innovations:
- Ex vivo baby skin models
- In vitro hair models
- Sebaceous gland models
- Pigmentation models
- Scar and stretch marks models
- Sensitive skin models
CTIBiosourcing
Top quality human cells, tissues and biological samples that provide the basis for research and innovation.
- National biobank for cancer
- International biobank for clients and partners
We offer: Human biological sample procurement & cell harvesting. Over 50 000 tissue samples in stock or on demand from bio-sourcing via a network of 200 healthcare partners worldwide
Specifically this includes:
- Human skin cells (dermal, epidermal, melanocytes, sebocytes ...)
- Oral and facial cells and tissues
- Subcutaneous tissues and organs
- Blood and bone marrow
- Cancer and associated cells
- Pathological tissues
- Cell purification and characterisation (CD34, 56, T, B)
Key product innovations:
- 3D printed tissue models
- Animal product free human cell models
Mission
To maximize the potential of tissues created by stem cell technologies and cancer biopsies for human therapeutic benefit
Key Points
More than 25 years experience
30CTICTI BIOTECH was founded in 2009 by Professor Colin McGuckin and Dr Nico Forraz, pioneers in the fields of regenerative medicine and cancer and creators of the world’s first artificial liver-like tissue using a unique form of embryonic-like adult stem cells. The core expertise of CTI BIOTECH is in cell manipulation, drug testing, biobanking and preclinical trials development. Cells as diverse as blood, immune, liver, pancreas, bone, cartilage, neural and skin-related are made in our laboratories.
Diverse technology platforms
30CTICTI BIOTECH is a fully licensed human tissue biobank and is developing proprietary in-house technologies using cancer and stem cells, but also has developmental partners in:
- Medical device development using human cells
- In vitro toxicology, drug testing and development
- Cosmetics and skin-drug testing and creation of skin models
- Provision of cell models for infectious diseases and cancer testing
International profile and partners
30CTICTI BIOTECH has already contributed to FDA registered and CE marked products available now through our partners. International projects in Europe, Asia and the United States have a proven success record.